Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial. Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola A, et al. J Clin Oncol 2022 Jan 12:JCO2102054. doi: 10.1200/JCO.21.02054.

Read + Share

Amedeo Smart

Independent Medical Education

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola A, et al. Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial. J Clin Oncol 2022 Jan 12:JCO2102054. doi: 10.1200/JCO.21.02054.
PMID: 35020465